AU2001218866A1 - Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration - Google Patents

Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration

Info

Publication number
AU2001218866A1
AU2001218866A1 AU2001218866A AU1886601A AU2001218866A1 AU 2001218866 A1 AU2001218866 A1 AU 2001218866A1 AU 2001218866 A AU2001218866 A AU 2001218866A AU 1886601 A AU1886601 A AU 1886601A AU 2001218866 A1 AU2001218866 A1 AU 2001218866A1
Authority
AU
Australia
Prior art keywords
waldeyer
strengthening
ring
mucosa
glucan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001218866A
Inventor
Luigi Mercuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DMG Italia SRL
Original Assignee
DMG Italia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DMG Italia SRL filed Critical DMG Italia SRL
Publication of AU2001218866A1 publication Critical patent/AU2001218866A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A product to be administered by nose for preventing inflammatory or hypertrophic forms and strengthening the immune action in the Waldeyer's ring and the oronasal mucosa consists of a physiological action with a high concentration in a polysaccharide such as glucan. In particular, two solutions having different concentrations have been specified, namely a first physiological solution with a glucan concentration equal to 0.25 % for cleaning the nasal fossae and with a preventive hydrating, reepithelializing capability of strengthening the immune action in the Waldeyer's ring and the oronasal mucosa, and a physiological solution with a glucan concentration equal to 2 % for hydrating and reepithelializing the nasal mucosa, capable of strengthening the immune response in the Waldeyer's ring duringthe acute phase of the inflammatory, hypertrophic forms of the same. Glucan is preferably used in the form beta -(1-3)-glucan.
AU2001218866A 2000-11-22 2000-11-22 Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration Abandoned AU2001218866A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000479 WO2002041900A1 (en) 2000-11-22 2000-11-22 Preparation for strengthening the immune response in the waldeyer's ring and the oronasal mucosa by intranasal administration

Publications (1)

Publication Number Publication Date
AU2001218866A1 true AU2001218866A1 (en) 2002-06-03

Family

ID=11133585

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001218866A Abandoned AU2001218866A1 (en) 2000-11-22 2000-11-22 Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration

Country Status (7)

Country Link
EP (1) EP1337260B1 (en)
AT (1) ATE290873T1 (en)
AU (1) AU2001218866A1 (en)
DE (1) DE60018812T2 (en)
ES (1) ES2237477T3 (en)
PT (1) PT1337260E (en)
WO (1) WO2002041900A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0225502D0 (en) * 2002-11-01 2002-12-11 Zoolife Internat Ltd Therapeutic and prophylactic preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045718A3 (en) * 1980-07-25 1983-01-19 Ciba-Geigy Ag Nasal compositions and method of preparing them
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
FR2780285B1 (en) * 1998-06-29 2001-10-05 Goemar Lab Sa USE OF ISOOSMOTIC SALINE SOLUTIONS, THEIR PREPARATION METHOD AND ANTI-INFLAMMATORY DRUGS BASED ON SUCH SOLUTIONS

Also Published As

Publication number Publication date
EP1337260A1 (en) 2003-08-27
DE60018812T2 (en) 2005-08-11
WO2002041900A1 (en) 2002-05-30
EP1337260B1 (en) 2005-03-16
DE60018812D1 (en) 2005-04-21
ES2237477T3 (en) 2005-08-01
ATE290873T1 (en) 2005-04-15
PT1337260E (en) 2005-05-31

Similar Documents

Publication Publication Date Title
HRP20030046B1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
AU690377B2 (en) Application of superoxide dismutase in liposomes
EP1158021A4 (en) Microgels and external preparations containing the same
ES2136883T3 (en) NEW IMPROVED FORMULATION OF AMINOGLUCOSIDE FOR ADMINISTRATION IN THE FORM OF AEROSOL.
WO2003024387A3 (en) Method and pharmaceutical composition for treating inflammation
CA2422850A1 (en) High citrate dialysate and uses thereof
HUP0104702A2 (en) Therapeutic agent for the suppression of snoring noises
NZ505919A (en) Nasal solutions
EE03016B1 (en) Oral Formulation for the Treatment of Central Dopamine Deficiency and Method for Its Preparation
WO2000004894A3 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
CN115607464B (en) Antibacterial stain-removing toothpaste and preparation method thereof
CA2136404A1 (en) Mucoadhesive, therapeutic or hygienic solid composition for application on oral or nasal mucosa
CA2507926A1 (en) Pharmaceutical composition comprising chito-oligomers
AU2002216748A1 (en) Method of treatment of seborrheic dermatitis
WO2002009679A3 (en) Use of 13-cis retinoic acid for the treatment of emphysema
TR200002078T2 (en) Synthetic polysaccharides, the process for their preparation and pharmaceutical compositions containing them.
AR015744A1 (en) USE OF DEXMEDETOMIDINE FOR SEDATION IN INTENSIVE THERAPY
DE60221227D1 (en) Xanthan gum-containing reepithelializing pharmaceutical preparations
AU2001218866A1 (en) Preparation for strengthening the immune response in the waldeyer's ring and theoronasal mucosa by intranasal administration
IE891314L (en) Pharmaceutical compositions of 1,5-d1¹(4-amidinophenoxy) pentane
SI0875248T1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
CN110623848A (en) Dentifrice with function of repairing oral mucosa and preparation method thereof
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
EP0209924A1 (en) New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
CN113384616A (en) Mucous membrane moisturizing cleaning agent and preparation method and application thereof